| Literature DB >> 31337077 |
Daniela Scribano1,2, Valeria Marzano3, Stefano Levi Mortera3, Meysam Sarshar4,5, Pamela Vernocchi3, Carlo Zagaglia1, Lorenza Putignani6, Anna Teresa Palamara4,7, Cecilia Ambrosi8,9.
Abstract
Carbapenem-resistant Acinetobacter baumannii strains cause life-threatening infections due to the lack of therapeutic options. Although the main mechanisms underlying antibiotic-resistance have been extensively studied, the general response to maintain bacterial viability under antibiotic exposure deserves to be fully investigated. Since the periplasmic space contains several proteins with crucial cellular functions, besides carbapenemases, we decided to study the periplasmic proteome of the multidrug-resistant (MDR) A. baumannii AB5075 strain, grown in the absence and presence of imipenem (IMP). Through the proteomic approach, 65 unique periplasmic proteins common in both growth conditions were identified: eight proteins involved in protein fate, response to oxidative stress, energy metabolism, antibiotic-resistance, were differentially expressed. Among them, ABUW_1746 and ABUW_2363 gene products presented the tetratricopeptide repeat motif, mediating protein-protein interactions. The expression switch of these proteins might determine specific protein interactions to better adapt to changing environmental conditions. ABUW_2868, encoding a heat shock protein likely involved in protection against oxidative stress, was upregulated in IMP-exposed bacteria. Accordingly, the addition of periplasmic proteins from A. baumannii cultured with IMP increased bacterial viability in an antioxidant activity assay. Overall, this study provides the first insights about the composition of the periplasmic proteins of a MDR A. baumannii strain, its biological response to IMP and suggests possible new targets to develop alternative antibiotic drugs.Entities:
Keywords: Acinetobacter baumannii; carbapenem-resistance; imipenem; oxidative stress; periplasmic proteome; β-lactamases
Year: 2019 PMID: 31337077 PMCID: PMC6679007 DOI: 10.3390/ijms20143451
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The growth curve of strain AB5075 cultivated in LB and LB supplemented with 6 µg/mL of IMP. The data are the means ± standard deviation from at least three independent experiments.
Figure 2Microbiological plate assay showing the growth of the imipenem (IMP)-susceptible A. baumannii ATCC 17978 strain in the nearby of a disk soaked with periplasmic proteins from strain AB5075. The microbiological disks applied on the surface of the seeded plates contained 15 µL of 1× (20 µg/mL) or 2× (40 µg/mL) periplasmic fractions extracted using the sucrose and lysozyme method. The plates seeded with strain AB5075 served as the positive control, whereas disks containing 15 µL of the buffers used to extract periplasmic proteins were used as the negative controls (not shown).
Figure 3The different protein profiles of cell-fractionation from A. baumannii AB5075. The periplasmic enriched fractions (PP) extracted from strain AB5075 cultured in control (LB) or LB supplemented with 6 μg/mL IMP (IMP) were resolved by SDS-PAGE and stained with Coomassie blue R-250. The protein profiles from the whole cell extract (WCE), the soluble (CYT) and membrane-associated (MEM) fractions extracted from strain AB5075 cultured in LB supplemented with IMP are also shown for comparison. M, molecular mass standards in kDa are given on the left. The gel slices excised and subjected to in-gel digestion are indicated on the right side. The reported image is representative of three independent experiments.
Differentially expressed periplasmic proteins identified in A. baumannii AB5075 grown in LB or LB supplemented with IMP using a semi-quantitative approach.
| UniProtKB Entry | Name | Locus Tag | Gene Name | PRED-TAT | SecretomeP 2.0 | SignalP 4.1 | LipoP 1.0 | Functional Categories | |
|---|---|---|---|---|---|---|---|---|---|
| (SP, Signal Peptide; MLCS, Most Likely Cleavage Site; Rs, Reliability Score) | (Thresholds = 0.5) | (D-cutoff 0.57) | (SpI: Signal Peptidase I; SpIIsignal Peptidase II; CYT: Cytoplasmic) | ( | |||||
| V5V8J3 | AdeT RND type efflux pump | ABUW_0009 | ABUW_0009 | Sec SP MLCS: 1–22 [AQA-AS]. Rs: 0.998 | 0.796 | 0.879 | SpI score = 23.7603 | Antibiotic resistance | 0.257 |
| A0A059ZEN4 | Polyketide cyclase/dehydrase | ABUW_0040 | ABUW_0040 | Sec SP MLCS: 1–21 [TGA-AS]. Rs: 0.989 | 0.873 | 0.740 | SpI score = 12.0307 | Fatty acid and phospholipid metabolism | 0.775 |
| A0A0D5YD86 | PF09917 family protein | ABUW_0139 | ABUW_0139 | Sec SP MLCS: 1–19 [ANA-AD]. Rs: 0.999 | 0.942 | 0.908 | SpI score = 22.236 | Unknown function | 0.586 |
| A0A0D5YDD6 | ABUW_0148 |
| Sec SP MLCS: 1–22 [ERA-VS]. Rs: 0.975 | 0.132 | 0.154 | CYT score = −0.200913 | Cell envelope | 0.241 | |
| A0A0B9W7U0 | Putative porin | ABUW_0166 | ABUW_0166 | Sec SP MLCS: 1–22 [ANA-YQ]. Rs: 0.999 | 0.955 | 0.890 | SpI score = 24.4957 | Unknown function | 0.660 |
| A0A0D5YEL2 | Inositol-1-monophosphatase | ABUW_0380 |
| Sec SP MLCS: 1–28 [ARA-AQ]. Rs: 0.963 | 0.077 | 0.291 | CYT score = −0.200913 | Energy metabolism | 0.034 |
| V5V9K9 | Putative phospholipid-binding protein MlaC | ABUW_0386 |
| Sec SP MLCS: 1–24 [AFA-AP]. Rs: 1.000 | 0.911 | 0.826 | SpI score = 14.7115 | Transport and binding proteins | 0.655 |
| A0A0D5YD51 | Cytokinin riboside 5’-monophosphate phosphoribohydrolase | ABUW_0389 |
| Sec SP MLCS: 1–19 [IFQ-QI]. Rs: 0.914 | 0.076 | 0.212 | SpI score = 0.389632 | Unknown function | 0.095 |
| V5V9H7 | 50S ribosomal protein L2 | ABUW_0409 |
| No SP. Rs: 1.000 | 0.715 | 0.142 | CYT score = −0.200913 | Protein synthesis | 0.556 |
| A0A059ZGZ2 | 50S ribosomal protein L6 | ABUW_0421 |
| No SP. Rs: 0.906 | 0.921 | 0.185 | CYT score = −0.200913 | Protein synthesis | 0.144 |
| A0A0D5YET6 | PF11306 family protein | ABUW_0459 | ABUW_0459 | Sec SP MLCS: 1–30 [ALA-MS]. Rs: 0.996 | 0.956 | 0.794 | SpI score = 21.0497 | Unknown function | 0.035 |
| A0A0D5YD61 | Transglycosylase SLT domain protein | ABUW_0465 |
| Sec SP MLCS: 1–24 [SYA-AE]. Rs 0.998 | 0.821 | 0.820 | SpI score = 16.2422 | Cell envelope | 0.801 |
| Q9L4P2 | OXA-23 | ABUW_0563 |
| Sec SP MLCS: 1–20 [CTV-QH]–Rs: 0.934 | 0.125 | 0.522 | SpII score = 7.79003 | Antibiotic resistance | 0.068 |
| A0A090B0M2 | Sel1 repeat protein | ABUW_0664 | ABUW_0664 | Sec SP MLCS: 1–19 [IFA-AD]. Rs: 0.998 | 0.948 | 0.924 | SpI score = 19.7066 | Protein fate | 0.274 |
| A0A0B9X9I7 | DcaP-like protein | ABUW_0826 | ABUW_0826 | Sec SP MLCS: 1–29 [ANA-AT]. Rs: 1.000 | 0.957 | 0.760 | SpI score = 13.4453 | Transport and binding proteins | 0.078 |
| V5VBV8 | Outer-membrane lipoprotein carrier protein | ABUW_0850 |
| Sec SP MLCS: 1–28 [AFA-AP]. Rs: 1.000 | 0.952 | 0.927 | SpI score = 25.1318 | Protein fate | 0.212 |
| A0A0Q1DNT0 | Succinate-CoA ligase [ADP-forming] subunit alpha | ABUW_0876 |
| Sec SP MLCS: 1–28 [AQA-LD]. Rs: 0.943 | 0.302 | 0.140 | CYT score = −0.200913 | Energy metabolism | 0.208 |
| A0A0D5YF99 | Carbamoyl-phosphate synthase small chain | ABUW_0894 |
| Sec SP MLCS: 1–22 [IGA-TG]. Rs: 0.986 | 0.269 | 0.204 | SpI score = −0.0909364 | Purines, pyrimidines, nucleosides, and nucleotides | 0.098 |
| A0A0D5YEE4 | Metallo-beta-lactamase domain protein | ABUW_0920 |
| No SP. Rs: 0.939 | 0.932 | 0.101 | CYT score = −0.200913 | Antibiotic resistance | 0.035 |
| V5VAD5 | Peptidoglycan-associated lipoprotein | ABUW_0992 |
| Sec SP MLCS: 1–29 [GDA-SG]. Rs: 0.990 | 0.912 | 0.583 | SpII score = 22.7919 | Cell envelope | 0.374 |
| V5VAE8 | 7-cyano-7-deazaguanine synthase | ABUW_1012 |
| Sec SP MLCS: 1–22 [AWA-QA]. Rs: 0.995 | 0.074 | 0.367 | SpI score = 2.3942 | Unknown function | 0.037 |
| V5VAT6 | ABC transporter permease | ABUW_1021 |
| Sec SP MLCS: 1–21 [SFA-AQ]. Rs: 0.996 | 0.848 | 0.833 | SpI score = 13.9335 | Transport and binding proteins | 0.323 |
| V5VAG2 | Periplasmic serine endoprotease DegP-like | ABUW_1027 |
| Sec SP MLCS: 1–24 [ANA-AV]. Rs: 0.999 | 0.888 | 0.660 | SpI score = 8.19702 | Protein fate | 0.566 |
| A0A0D5YFS0 | Peptidase, M16 family | ABUW_1082 |
| Sec SP MLCS: 1–23 [SFA-QT]. Rs: 0.999 | 0.728 | 0.822 | SpI score = 14.1822 | Protein fate | 0.099 |
| V5VB00 | PF04402 family protein | ABUW_1108 | ABUW_1108 | Sec SP MLCS: 1–21 [VFA-QD]. Rs: 1.000 | 0.885 | 0.809 | SpI score = 14.5801 | Unknown function | 0.054 |
| A0A0D8GKI2 | Phosphate-binding protein PstS | ABUW_1115 |
| Sec SP MLCS: 1–25 [ANA-AR]. Rs: 0.999 | 0.942 | 0.739 | SpI score = 15.3657 | Transport and binding proteins | 0.750 |
| V5VBD5 | ErfK/YbiS/YcfS/YnhG family | ABUW_1189 |
| Sec SP MLCS: 1–21 [ALA-AS]. Rs: 0.999 | 0.950 | 0.916 | SpI score = 18.7128 | Cell envelope | 0.942 |
| D6NSM8 | Beta-lactamase ADC7 | ABUW_1194 |
| Sec SP MLCS: 14–36 [IYA-GN]. Rs: 0.917 | 0.844 | 0.496 | SpI score = 5.57966 | Antibiotic resistance | 0.206 |
| A0A0D5YG57 | Aminopeptidase | ABUW_1203 |
| Sec SP MLCS: 24–49 [IFA-SN]. Rs: 0.996 | 0.618 | 0.528 | SpI score = 1.53431 | Protein fate | 0.795 |
| V5VAU8 | Superoxide dismutase | ABUW_1216 |
| No SP. Rs: 0.955 | 0.918 | 0.103 | CYT score = −0.200913 | Response to oxidative stress | 0.270 |
| V5VBL0 | Lytic murein transglycosylase B | ABUW_1243 |
| Sec SP MLCS: 1–28 [AQA-ND]. Rs: 0.999 | 0.826 | 0.783 | SpI score = 15.767 | Cell envelope | 0.571 |
| A0A090C137 | 3-phosphoshikimate 1-carboxyvinyltransferase | ABUW_1366 |
| Sec SP MLCS: 1–27 [IVA-EK]. Rs: 0.978 | 0.077 | 0.304 | SpI score = 1.23597 | Amino acid biosynthesis | 0.194 |
| V5VBJ4 | Aconitate hydratase B | ABUW_1593 |
| No SP. Rs: 0.989 | 0.386 | 0.091 | CYT score = −0.200913 | Fatty acid and phospholipid metabolism | 0.099 |
| A0A059ZHT5 | Tetratricopeptide repeat protein | ABUW_1746 |
| Sec SP MLCS: 1–21 [LYA-NI]. Rs: 0.998 | 0.936 | 0.715 | SpI score = 9.11005 | Protein fate | 0.019 |
| A0A0D5YHX0 | Quinoprotein glucose dehydrogenase B | ABUW_1762 |
| Sec SP MLCS: 1–25 [AFA-DI]. Rs: 0.999 | 0.928 | 0.753 | SpI score = 7.30243 | Cellular processes | 0.416 |
| A0A086HXI4 | CTP synthase | ABUW_1825 |
| Sec SP MLCS: 1–21 [ISA-AS]. Rs: 0.987 | 0.058 | 0.317 | SpI score = 1.34202 | Purines, pyrimidines, nucleosides, and nucleotides | 0.137 |
| A0A0D5YHL1 | 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase | ABUW_2076 |
| Sec SP MLCS: 1–19 [AIA-KQ]. Rs:0.971 | 0.103 | 0.243 | SpI score = 4.55959 | Cellular processes | 0.374 |
| A0A0D5YIT2 | Molybdate ABC transporter substrate-binding protein | ABUW_2079 |
| Sec SP MLCS: 1–29 [AKA-ES]. Rs: 0.999 | 0.777 | 0.626 | SpI score = 8.37936 | Transport and binding proteins | 0.512 |
| A0A0D5YI49 | Oligopeptidase A | ABUW_2224 |
| Sec SP MLCS: 1–24 [ASA-EA]. Rs: 0,997 | 0.525 | 0.749 | SpI score = 12.5788 | Protein fate | 0.989 |
| A0A077GP18 | Chaperone SurA | ABUW_2268 |
| Sec SP MLCS: 1–32 [SFA-QP]. Rs: 1.000 | 0.425 | 0.762 | SpI score = 16.0755 | Protein fate | 0.160 |
| V5XWY4 | Polyisoprenoid-binding protein | ABUW_2293 | ABUW_2293 | Sec SP MLCS: 1–21 [TLA-AP]. Rs: 0.999 | 0.924 | 0.873 | SpI score = 19.451 | Unknown function | 0.143 |
| V5VDN7 | Amino acid ABC transporter substrate-binding protein | ABUW_2333 |
| Sec SP MLCS: 1–26 [IQA-AD]. Rs: 0.999 | 0.958 | 0.732 | SpI score = 12.943 | Transport and binding proteins | 0.222 |
| A0A077GKV3 | Glutaminase-asparaginase | ABUW_2359 |
| Sec SP MLCS: 1–24 [LYA-KN]. Rs: 0.991 | 0.824 | 0.842 | SpI score = 17.3321 | Energy metabolism | 0.559 |
| V5VDR1 | Tetratricopeptide repeat family protein | ABUW_2363 | ABUW_2363 | Sec SP MLCS: 1–24 [VYA-AR]. Rs: 0.988 | 0.127 | 0.427 | SpI score = 7.46629 | Protein fate | 0.005 |
| A0A0D5YK68 | Uncharacterized protein | ABUW_2616 | ABUW_2616 §§§ | Sec SP MLCS: 1–19 [SLV-DD]. Rs: 0.872 | 0.097 | 0.299 | CYT score = −0.200913 | Unknown function | 0.024 |
| A0A0D8GPY7 | Uncharacterized protein | ABUW_2660 | ABUW_2660 | Sec SP MLCS: 1–20 [SYA-QS]. Rs: 0.996 | 0.842 | 0.749 | SpI score = 13.0805 | Unknown function | 0.237 |
| A0A0D5YJD8 | Putative peptidase, M23/M37 family | ABUW_2738 |
| Sec SP MLCS: 1–24 [AMA-EL]. Rs: 1.000 | 0.870 | 0.860 | SpI score = 11.5496 | Cell envelope | 0.340 |
| A0A0E1JMR4 | Heat shock protein | ABUW_2868 | ABUW_2868 | Sec SP MLCS: 1–24 [SNT-QA]. Rs: 0.964 | 0.945 | 0.747 | SpII score = 10.5977 | Response to oxidative stress | 0.048 |
| A0A0D5YLD9 | Acyl-CoA thioesterase | ABUW_2912 |
| No SP. Rs: 0.439 | 0.944 | 0.233 | CYT score = −0.200913 | Fatty acid and phospholipid metabolism | 0.179 |
| A0A0D5YL61 | Triacylglycerol lipase | ABUW_2914 |
| Sec SP MLCS: 1–36 [AQA-AD]. Rs: 1.000 | 0.589 | 0.873 | SpI score = 24.4375 | Cellular processes | 0.062 |
| A0A0D5YHR1 | Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase PgaB | ABUW_2960 |
| Sec SP MLCS: 1–27 [ALA-NP]. Rs: 0.998 | 0.072 | 0.223 | CYT score = −0.200913 | Biofilm formation | 0.481 |
| V5VG70 | LysM domain/BON superfamily protein | ABUW_3106 | ABUW_3106 | No SP. Rs: 0.830 | 0.918 | 0.108 | CYT score = −0.200913 | Unknown function | 0.822 |
| V5VHN7 | 3-oxoacyl-(Acyl-carrier-protein) reductase | ABUW_3108 |
| Sec SP MLCS: 1–22 [AIA-QQ]. Rs: 0.992 | 0.181 | 0.230 | SpI score = 2.77001 | Fatty acid and phospholipid metabolism | 0.211 |
| V5VFX0 | Malonyl CoA-acyl carrier protein transacylase | ABUW_3109 |
| No SP. Rs: 0.330 | 0.538 | 0.181 | CYT score = −0.200913 | Fatty acid and phospholipid metabolism | 0.677 |
| V5VGJ7 | Ribulose-phosphate 3-epimerase | ABUW_3231 |
| Sec SP MLCS: 1–20 [RLG-ED]. Rs: 0.731 | 0.076 | 0.207 | CYT score = −0.200913 | Energy metabolism | 0.205 |
| V5VGP5 | Pantothenate synthetase | ABUW_3295 |
| Sec SP MLCS: 1–19 [ARA-AR]. Rs: 0.991 | 0.120 | 0.181 | CYT score = −0.200913 | Biosynthesis of cofactors, prosthetic groups, and carriers | 0.085 |
| A0A077GA87 | Enoyl-[acyl-carrier-protein] reductase [NADH] | ABUW_3365 |
| Sec SP MLCS: 1–29 [AQA-LH]. Rs: 0.968 | 0.0921 | 0.276 | CYT score = −0.200913 | Fatty acid and phospholipid metabolism | 0.231 |
| V5VH43 | C-terminal processing peptidase family protein | ABUW_3385 |
| Sec SP MLCS: 1–28 [ARA-AT]. Rs: 0.998 | 0.682 | 0.592 | SpI score = 7.74808 | Protein fate | 0.308 |
| V5VH86 | 50S ribosomal protein L1 | ABUW_3593 |
| No SP. Rs: 0.218 | 0.946 | 0.168 | CYT score = −0.200913 | Protein synthesis | 0.413 |
| A0A0D5YME7 | LysM domain/BON superfamily protein | ABUW_3722 | ABUW_3722 | Sec SP MLCS: 1–39 [VHA-TS]. Rs: 0.997 | 0.858 | 0.540 | SpI score = 7.26442 | Unknown function | 0.124 |
| A0A0F7YYU4 | UDP-N-acetyl-mannosamine dehydrogenase | ABUW_3828 |
| Sec SP MLCS: 1–25 [TFA-AH]. Rs: 0.997 | 0.169 | 0.488 | SpI score = 1.31476 | Cellular processes | 0.079 |
| W8FNF9 | Peptidyl-prolyl cis-trans isomerase | ABUW_3835 |
| Sec SP MLCS: 1–19 [VFA-AA]. Rs: 0.991 | 0.135 | 0.904 | SpI score = 19.8542 | Protein fate | 0.923 |
| A0A0D5YNX0 | Thiol:disulfide interchange protein | ABUW_3846 |
| Sec SP MLCS: 1–22 [AMA-AD]. Rs: 1.000 | 0.880 | 0.905 | SpI score = 22.2592 | Protein fate | 0.204 |
| A0A0D5YMJ1 | N5-carboxyaminoimidazole ribonucleotide synthase | ABUW_3885 |
| Sec SP MLCS: 1–20 [AQA-AL]. Rs: 0.972 | 0.107 | 0.239 | CYT score = −0.200913 | Purines, pyrimidines, nucleosides, and nucleotides | 0.323 |
| C5HUY1 | Beta-lactamase | ABUW_4052 |
| Sec SP MLCS: 1–18 [AYA-SE]. Rs: 0.997 | 0.092 | 0.604 | SpI score = 3.88651 | Antibiotic resistance | 0.498 |
(*) Asterisks indicate those proteins in which the Tat 1.0 server recognized a potential Tat signal peptide but no Tat motif. (§) One section sign indicates essential genes, two non-essential genes, three the gene with no orthologue in strain ATCC 17978. Both TMHMM 2.0 and TOPCONS servers predicted no TMH and, therefore, was omitted.
Figure 4The distribution of functional categories of putative periplasmic proteins identified in the periplasmic fractions of strain AB5075 grown in the presence and the absence of IMP. The assignment to each functional category was based on TIGR annotation [http://www.tigr.org] and on available literature of single proteins.
Figure 5Semi-quantitative analysis of differentially expressed periplasmic proteins from strain AB5075 grown in LB or LB supplemented with IMP. The data are the means ± standard deviation from three independent experiments. The functional categories of periplasmic proteins identified assigned as previously described are shown. The emPAI and statistical significance values are shown. Asterisks represent p values evaluated by t test; ** p < 0.01, * p < 0.05.
Figure 6The survival rates of AB5075 cells incubated with periplasmic fractions extracted from A. baumannii cultures grown in the presence and absence of IMP and challenged with 2 mM of H2O2. Bacterial starting viability was controlled by re-suspending the inoculum used in this assay (1 × 106/mL) in sodium chloride 0.9% (NaCl) which was set as 100% (not shown). Due to its composition, the periplasmic extraction buffer TSL (30 mM Tris-HCl–20% sucrose (pH 8.1), lysozyme 100 mg/mL in 0.1 M EDTA [pH 7.3]) was used as the control. The untreated and H2O2-treated bacteria resuspended in the periplasmic extraction buffer TSL in the presence of periplasmic extracts extracted from cells grown in LB (PPLB) or in LB supplemented with IMP (PPIMP). The untreated and H2O2-treated bacteria with or without the addition of 50 µg/mL of bovine serum albumin (BSA) to buffer hydroxyl radicals served as controls. Asterisks represent p values evaluated by one-way ANOVA; *** p < 0.001, ** p < 0.01, * p < 0.05.